Search research articles
Contact Us
Filters
Showing results (381-390 of 567) with videos related to
Page
of 57
Sort By:
Emerging Infectious Diseases
|
June 8, 2007
International spread of multidrug-resistant Salmonella Schwarzengrund in food products
Frank M Aarestrup, Rene S Hendriksen, Jana Lockett, et al.
The Lancet. Oncology
|
April 3, 2023
Belzutifan plus cabozantinib for patients with advanced clear cell renal cell carcinoma previously treated with immunotherapy: an open-label, single-arm, phase 2 study
Toni K Choueiri, David F McDermott, Jaime Merchan, et al.
ESMO Open
|
February 8, 2021
A matching-adjusted indirect comparison of combination nivolumab plus ipilimumab with BRAF plus MEK inhibitors for the treatment of BRAF-mutant advanced melanoma<sup>☆</sup>
A A Tarhini, K Toor, K Chan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 10, 2009
Phase II Trial of Temozolomide and Sorafenib in Advanced Melanoma Patients with or without Brain Metastases
Ravi K Amaravadi, Lynn M Schuchter, David F McDermott, et al.
Foodborne Pathogens and Disease
|
July 5, 2005
Characterization of Salmonella Typhimurium of animal origin obtained from the National Antimicrobial Resistance Monitoring System
S Zhao, P J Fedorka-Cray, S Friedman, et al.
Nature Medicine
|
April 23, 2021
Inhibition of hypoxia-inducible factor-2α in renal cell carcinoma with belzutifan: a phase 1 trial and biomarker analysis
Toni K Choueiri, Todd M Bauer, Kyriakos P Papadopoulos, et al.
Clinical and Experimental Immunology
|
September 5, 2012
Differential effects of infliximab on absolute circulating blood leucocyte counts of innate immune cells in early and late rheumatoid arthritis patients
L R Coulthard, J Geiler, R J Mathews, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 1, 2019
Angiogenic Factor and Cytokine Analysis among Patients Treated with Adjuvant VEGFR TKIs in Resected Renal Cell Carcinoma
Wenxin Xu, Maneka Puligandla, Judith Manola, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
July 12, 2024
Generation and Characterization of Ex Vivo Expanded Tumor-infiltrating Lymphocytes From Renal Cell Carcinoma Tumors for Adoptive Cell Therapy
David J Einstein, Brian Halbert, Thomas Denize, et al.
Cancer
|
May 21, 2016
A phase 1 study of buparlisib and bevacizumab in patients with metastatic renal cell carcinoma progressing on vascular endothelial growth factor-targeted therapies
Rana R McKay, Guillermo De Velasco, Lillian Werner, et al.
Page
of 57
Search research articles
Search
Showing results (381-390 of 567) with videos related to
Sort By:
Page
of 57
Emerging Infectious Diseases
|
June 8, 2007
International spread of multidrug-resistant Salmonella Schwarzengrund in food products
Frank M Aarestrup, Rene S Hendriksen, Jana Lockett, et al.
The Lancet. Oncology
|
April 3, 2023
Belzutifan plus cabozantinib for patients with advanced clear cell renal cell carcinoma previously treated with immunotherapy: an open-label, single-arm, phase 2 study
Toni K Choueiri, David F McDermott, Jaime Merchan, et al.
ESMO Open
|
February 8, 2021
A matching-adjusted indirect comparison of combination nivolumab plus ipilimumab with BRAF plus MEK inhibitors for the treatment of BRAF-mutant advanced melanoma<sup>☆</sup>
A A Tarhini, K Toor, K Chan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 10, 2009
Phase II Trial of Temozolomide and Sorafenib in Advanced Melanoma Patients with or without Brain Metastases
Ravi K Amaravadi, Lynn M Schuchter, David F McDermott, et al.
Foodborne Pathogens and Disease
|
July 5, 2005
Characterization of Salmonella Typhimurium of animal origin obtained from the National Antimicrobial Resistance Monitoring System
S Zhao, P J Fedorka-Cray, S Friedman, et al.
Nature Medicine
|
April 23, 2021
Inhibition of hypoxia-inducible factor-2α in renal cell carcinoma with belzutifan: a phase 1 trial and biomarker analysis
Toni K Choueiri, Todd M Bauer, Kyriakos P Papadopoulos, et al.
Clinical and Experimental Immunology
|
September 5, 2012
Differential effects of infliximab on absolute circulating blood leucocyte counts of innate immune cells in early and late rheumatoid arthritis patients
L R Coulthard, J Geiler, R J Mathews, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 1, 2019
Angiogenic Factor and Cytokine Analysis among Patients Treated with Adjuvant VEGFR TKIs in Resected Renal Cell Carcinoma
Wenxin Xu, Maneka Puligandla, Judith Manola, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
July 12, 2024
Generation and Characterization of Ex Vivo Expanded Tumor-infiltrating Lymphocytes From Renal Cell Carcinoma Tumors for Adoptive Cell Therapy
David J Einstein, Brian Halbert, Thomas Denize, et al.
Cancer
|
May 21, 2016
A phase 1 study of buparlisib and bevacizumab in patients with metastatic renal cell carcinoma progressing on vascular endothelial growth factor-targeted therapies
Rana R McKay, Guillermo De Velasco, Lillian Werner, et al.
Page
of 57